A50™ is formulated to work by way of multiple physiological pathways, including inhibition of cyclic adenosine monophosphate (cAMP)-degrading phosphodiesterases (PDEs), regulation of GH-releasing hormones and somatotropin-release inhibiting factor, as well as interaction with hormonal (luteinizing hormone and testosterone) and neuronal (dopaminergic) pathways.